Human Antibodies

Volume

29, 4 issues

Latest issue

29:3 online 2 July 2021

Next issue

29:4 scheduled for October 2021

Back volumes

From volume 1, 1990

ISSN print

1093-2607

ISSN online

1875-869X

Aims & Scope

Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology, along with factors that modulate host antibody repertoire and effectiveness, such as vaccines, infectious agents, and microbiome. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.

Editorial Board

Editor-in-Chief

Mark C. Glassy, PhD
UC San Diego
Moores Cancer Center
Translational Neuro-Oncology Laboratory

La Jolla, CA
USA
Tel.: +1 858 566 9490
Email: markglassy@aol.com 

Editorial Board

Robert M. Anthony, PhD
Massachusetts General Hospital, Center for Immunology & Inflammatory Diseases, Boston
USA

Dimitrios P. Bogdanos, MBA, MD, PhD
University of Thessaly, Department of Rheumatology and Clinical Immunology, Thessaly
Greece

Dennis R. Burton, PhD
The Scripps Research Institute, Department of Immunology & Microbial Science - IMM2, La Jolla
USA

Paul J. Carter, PhD
Genentech, Inc., Department of Antibody Engineering, San Francisco
USA

Stefan Dübel, PhD
Technische Universitat Braunschweig, Braunschweig
Germany

Gilad Halpert, PhD
Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer
Israel

Michael Hust, PhD
Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Braunschweig
Germany

Angray S. Kang, BSc (Hons), PhD
Queen Mary University of London, Centre for Oral Immunobiology and Regenerative Medicine, Bart's and London Medical and Dental School, London
United Kingdom

Renate Kunert, PhD
Universität für Bodenkultur, Department of Biotechnology, Vienna
Austria

Alois B. Lang, PhD
GeNeuro SA, Geneva
Switzerland

James W Larrick, MD, PhD
Regenerative Sciences Institute, Sunnyvale
USA

Julian Ma, FDS RCS(Ed), PhD
Institute for Infection and Immunity, St. Georges University of London, London
United Kingdom

James D. Marks, MD, PhD
San Francisco General Hospital, Department of Anesthesia, San Francisco
USA

Sherrie L. Morrison, PhD
UCLA, Department of Microbiology, Immunology and Molecular Genetics, Los Angeles
USA

David Naor, PhD
The Hebrew University of Jerusalem, Faculty of Medicine, The Lautenberg Center of Immunology and Cancer Research, Jerusalem
Israel

Paul W.H.I. Parren, PhD
Genmab, Utrecht
The Netherlands

Carlo Perricone, MD, PhD
University of Perugia, Department of Medicine and Surgery, Perugia
Italy

Andreas A. Plückthun, PhD
University of Zurich, Department of Biochemistry, Zurich
Switzerland

Matthew D. Scharff, PhD
Albert Einstein College of Medicine, Department of Cell Biology, Bronx, USA

Yehuda Shoenfeld, MD., FRCP, MaACR
Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer
Israel

Sachdev Sidhu, PhD
University of Toronto, The Donnelly Centre, Toronto
Canada

Leonidas Stamatatos, PhD
Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle
USA

Michael Steinitz, PhD
The Hebrew University, Department of Pathology, Jerusalem, Israel

Mohammad Taheri, PhD
Shahid Beheshti University of Medical Sciences, Department of Medical Genetics, Tehran
Iran

Jean-Luc Teillaud, PhD
French Institute of Health and Medical Research (INSERM), Paris
France

Louis M. Weiner, MD
Georgetown Lombardi Comprehensive Cancer Center, Department of Oncology, Washington
USA

Gregory Winter, PhD
Trinity College, Cambridge
United Kingdom

K. Dane Wittrup, PhD
Massachusetts Institute of Technology, Department of Chemical Engineering and Biological Engineering, Cambridge
USA

Susan Zolla-Pazner, PhD
Icahn School of Medicine at Mount Sinai, Departments of Medicine (Division of Infectious Diseases) and Microbiology, New York
USA

Author Guidelines

SUBMISSION OF MANUSCRIPT

By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.

Authors are requested to submit their manuscript electronically to the journal's submission system.

Required files for final submissions
After the article has been accepted, the authors should submit the final version as source files, including a word processor file of the text, such as Word or LateX (If using LaTeX, please use the standard article.sty as a style file and also send a PDF version of the LaTeX file).

Colour figures
It is possible to have figures printed in colour, provided the cost of their reproduction is paid for by the author. See Preparation of Manuscripts for the required file formats.

Open access option
The IOS Press Open Library offers authors an open access (OA) option. By selecting the OA option, the article will be freely available from the moment it is published, also in the pre-press module. In the Open Library the article processing charges are paid in the form of an open access fee. Authors will receive an open access order form upon acceptance of their article. Open access is entirely optional.

See also our website for more information about the IOS Press Open Library, and also to check if there are any institutional agreements that you might be eligible for.

PREPARATION OF MANUSCRIPTS

Organization of the paper and style of presentation
Manuscripts must be written in English. Authors whose native language is not English are advised to seek the advice of a native English speaker, before submitting their manuscripts.

Peerwith offers a language and copyediting service to all scientists who want to publish their manuscript in scientific peer-reviewed periodicals and books.

Manuscripts should be prepared with wide margins and double spacing throughout, including the abstract, footnotes and references. Every page of the manuscript, including the title page, references, tables, etc., should be numbered. However, in the text no reference should be made to page numbers; if necessary, one may refer to sections. Try to avoid the excessive use of italics and bold face.

Manuscripts should be organized in the following order:

Title page
Body of text (divided by subheadings)
Acknowledgements
References
Tables
Figure captions
Figures
Headings and subheadings should be numbered and typed on a separate line, without indentation.

SI units should be used, i.e., the units based on the metre, kilogramme, second, etc.

Title page
The title page should provide the following information:

- Title (should be clear, descriptive and not too long)
- Name(s) of author(s); please indicate who is the corresponding author
- Full affiliation(s)
- Present address of author(s), if different from affiliation
- Complete address of corresponding author, including tel. no., fax no. and e-mail address
- Abstract
- Keywords

Abstract
The abstract should be clear, descriptive, self-explanatory and not longer than 200 words, it should also be suitable for publication in abstracting services.
The abstract for research papers should follow the “structured abstract” format. Section labels should be in bold uppercase letters followed by a colon, and each section will begin on a new line.
BACKGROUND:
OBJECTIVE:
METHODS:
RESULTS:
CONCLUSIONS:

Tables
Number as Table 1, Table 2 etc, and refer to all of them in the text.

Each table should be provided on a separate page of the manuscript. Tables should not be included in the text.

Each table should have a brief and self-explanatory title.

Column headings should be brief, but sufficiently explanatory. Standard abbreviations of units of measurement should be added between parentheses.

Vertical lines should not be used to separate columns. Leave some extra space between the columns instead.

Any explanations essential to the understanding of the table should be given in footnotes at the bottom of the table.

REFERENCES

Place citations as numbers in square brackets in the text. All publications cited in the text should be presented in an alphabetical list of references at the end of the manuscript in the following style:

[1] B. Newman and E.T. Liu, Perspective on BRCA1, Breast Disease 10 (1998), 3-10.
[2] D.F. Pilkey, Happy conservation laws, in: Neural Stresses, J. Frost, ed., Controlled Press, Georgia, 1995, pp. 332-391.
[3] E. Wilson, Active vibration analysis of thin-walled beams, Ph.D. Dissertation, University of Virginia, 1991.

Footnotes
Footnotes should only be used if absolutely essential. In most cases it is possible to incorporate the information in the text.

If used, they should be numbered in the text, indicated by superscript numbers and kept as short as possible.

Figures

Number figures as Fig. 1, Fig. 2, etc and refer to all of them in the text.

Each figure should be provided on a separate sheet. Figures should not be included in the text.

Colour figures can be included, provided the cost of their reproduction is paid for by the author.

For the file formats of the figures please take the following into account:
- Line art should be have a minimum resolution of 600 dpi, save as EPS or TIFF
Grayscales (incl photos) should have a minimum resolution of 300 dpi (no lettering), or 500 dpi (when there is lettering); save as tiff
- Do not save figures as JPEG, this format may lose information in the process
- Do not use figures taken from the Internet, the resolution will be too low for printing
- Do not use colour in your figures if they are to be printed in black & white, as this will reduce the print quality (note that in software often the default is colour, you should change the settings)
- For figures that should be printed in colour, please send a CMYK encoded EPS or TIFF
- Figures should be designed with the format of the page of the journal in mind. They should be of such a size as to allow a reduction of 50%.

On maps and other figures where a scale is needed, use bar scales rather than numerical ones, i.e., do not use scales of the type 1:10,000. This avoids problems if the figures need to be reduced.

Each figure should have a self-explanatory caption. The captions to all figures should be typed on a separate sheet of the manuscript.

Photographs are only acceptable if they have good contrast and intensity.

COPYRIGHT

Copyright of your article
Authors submitting a manuscript do so on the understanding that they have read and agreed to the terms of the IOS Press Author Copyright Agreement.

Quoting from other publications
An author, when quoting from someone else's work or when considering reproducing figures or table from a book or journal article, should make sure that he is not infringing a copyright. Although in general an author may quote from other published works, he should obtain permission from the holder of the copyright if he wishes to make substantial extracts or to reproduce tables, plates or other figures. If the copyright holder is not the author of the quoted or reproduced material, it is recommended that the permission of the author should also be sought. Material in unpublished letters and manuscripts is also protected and must not be published unless permission has been obtained. Submission of a paper will be interpreted as a statement that the author has obtained all the necessary permission. A suitable acknowledgement of any borrowed material must always be made.

PROOFS

The corresponding author will receive a PDF proof and is asked to check this proof carefully (the publisher will execute a cursory check only). Corrections other than printer's errors, however, should be avoided. Costs arising from such corrections will be charged to the authors.

PURCHASES

How to order reprints, a PDF file, journals, or IOS Press books
The corresponding author of a contribution to the journal will receive a complimentary PDF Author’s Copy of the article, unless otherwise stated. This PDF copy is watermarked and for personal use only. A free PDF copy will not be provided for conference proceedings and abstract issues. An order form for a PDF file without watermark, reprints or additional journal copies will be provided along with the PDF proof.

If you wish to order reprints of an earlier published article, please contact the publisher for a quotation. IOS Press, Fax: +31 20 687 0019. Email: editorial@iospress.nl.

An author is entitled to 25 % discount on IOS Press books. See Author's discount (25%) on all IOS Press book publications.

KUDOS

Authors of published articles (non-prepress, final articles) will be contacted by Kudos. Kudos is a service that helps researchers maximize the impact and visibility of their research. It allows authors to enrich their articles with lay metadata, add links to related materials and promote their articles through the Kudos system to a wider public. Authors will receive no more than three emails: one invitation and a maximum of two reminders to register for the service and link the published article to their profile. Using and registering for Kudos remains entirely optional. For more information, please have a look at our authors section.

HOW TO PROMOTE YOUR WORK

Would you like some pointers on how to help your research achieve a wider reach and greater impact? Please consult our Promotional Toolkit for Authors for tips.

 

Abstracted/Indexed in

Academic Search
Cambridge Scientific Abstracts
Chemical Abstracts Service (CAS)
CSA Illumina
EBSCO Databases
Embase
Index Medicus
INIST - Institute for Scientific and Technical Information
MEDLINE
PubMed
SciVerse Scopus
SUBIS
Ulrich's Periodicals Directory
Web of Science: Biological Abstracts
Web of Science: BIOSIS Previews

Peer Review Policy

Human Antibodies is a peer-reviewed journal. Articles submitted to the journal undergo a single blind peer review process. This means that the identity of the authors is known to the reviewers but the identity of the reviewers is not communicated to the authors.

All submitted manuscripts are subjected to initial appraisal by the Editor-in-Chief and, if found suitable for further consideration, to rigorous peer review by independent, anonymous expert referees. Reasons to reject a paper in the pre-screening process could for example be because the work does not fall within the aims and scope, the writing is of poor quality, the instructions to authors were not followed or the presented work is not novel.

Papers deemed suitable to the journal will be forwarded to two reviewers. Reviewers are asked to excuse themselves from reviewing a submission if a conflict makes them unable to make an impartial scientific judgment or evaluation. Conflicts of interest include but are not limited to: collaboration with the authors in the past three years; any professional or financial affiliations that may be perceived as a conflict of interest; a history of personal differences with the author(s). The Editor-in-Chief strives to ensure a typical turnaround time of 3 months.

Reviewers are asked to judge a paper on at least:

  • Significance to field
  • Relevance to journal
  • Methodology
  • Data analysis
  • Literature review
  • Writing style/clarity

Based on the received reviews the Editor-in-Chief will write a decision letter:

  1. Accept
  2. Minor revisions required
  3. Major revisions required
  4. Revise and resubmit
  5. Reject

They mean the following:

  1. The manuscript is suitable for publication and only requires minor polishing; thus, no further reviews are requested.
  2. The authors are required to make moderate changes to their manuscript. The manuscript becomes acceptable for publication if the changes proposed by the reviewers and editors are successfully addressed. The revised manuscript will be examined by the Editor-in-Chief and possibly sent back to all (or a selection of) reviewers for a second round of reviews. Authors are requested to provide a letter to the reviewers detailing the improvements made for the resubmission.
  3. The manuscript cannot be accepted for publication in its current form. However, a major revision addressing all issues raised by the reviewers may be acceptable for publication. The revised manuscript will undergo a full second round of review. Authors are requested to provide a letter to the reviewers detailing the improvements made for the resubmission.
  4. In its current form, the manuscript is not suitable for publication. A resubmission would require substantial revisions and is only encouraged in special cases. The resubmitted manuscript will be considered as a new submission.
  5. The manuscript is rejected as it is deemed to be out of scope, not relevant, or not meeting the journal’s quality standards in terms of significance, novelty, and/or presentation.

Authors are notified by the Editor-in-Chief, whose decision is final.

Do you Wish to Receive Updates? – If you would like to receive news updates about our journal Human Antibodies (HAB), let us know by signing up at: tiny.cc/HABsignup. View the recent HAB mailing here.

HAB red journal signup banner